Author Interviews, Cancer Research, Cost of Health Care / 16.09.2025

[caption id="attachment_70691" align="aligncenter" width="500"]oncology-cancer-billing-services Pexels image[/caption] Cancer care is going through big changes due to advancement in healthcare research. For many years, the main treatments were surgery, chemotherapy, and radiation. These are still important, but now new options like immunotherapy and targeted therapy are improving results for patients. But with these new treatments also come new challenges.  They have completely changed how cancer clinics handle billing and payments. For oncology providers, keeping up with these changes is important to stay financially secure. This article looks at new cancer treatments, how they affect billing, the challenges clinics face, and how trusted oncology billing services providers help providers handle these issues.
Cost of Health Care, Medication Costs / 05.03.2025

[caption id="attachment_66993" align="aligncenter" width="500"]medication-costs-discuss-with-doctor Photo By: Kaboompics.com[/caption]

Understanding the Importance of Transparent Communication

The conversation around medication costs is often overlooked, yet it is an essential aspect of effective healthcare management. Transparent communication with your healthcare provider can pave the way for finding affordable options while ensuring that the quality of care is not compromised. Patients often hesitate to bring up financial concerns, fearing it may affect the quality of treatment offered. However, discussing medication costs openly allows your doctor to consider various factors that could lead to more cost-effective treatments. For instance, health providers, with the patient's consent, can explore alternative medications or treatment plans that are equally effective but less expensive. Additionally, transparent communication fosters a stronger doctor-patient relationship where the patient feels supported in all aspects of their care. Using resources like BuzzRx further enhances your ability to find savings on prescriptions, ultimately aiding in more manageable healthcare costs.
Alzheimer's - Dementia, Author Interviews, Cost of Health Care, Medicare, UCLA / 15.10.2024

MedicalResearch.com Interview with: [caption id="attachment_64014" align="alignleft" width="150"]Frank F. Zhou  |  he/himMD Candidate, Class of 2025 David Geffen School of Medicine at UCLA Frank F Zhou[/caption] Frank F. Zhou  |  he/him MD Candidate, Class of 2025 David Geffen School of Medicine at UCLA MedicalResearch.com: What is the background for this study? What is Lecanemab used for?  How is it given to patients? Response: Lecanemab is a new infusion therapy for Alzheimer's disease. Its dosing is based on each patient's body weight (10 mg/kg every two weeks), but the drug is only available in 500 mg and 200 mg single-use vials, meaning that any leftover drug in vials must be thrown away. Given that lecanemab is expected to cost Medicare billions of dollars each year, we hypothesized that discarded drug could result in significant wasteful spending.
Author Interviews, Cost of Health Care, Telemedicine / 09.07.2024

The United States currently has a doctor-patient ratio of 2.6 in 1000, and although it is above the recommended 1:1000, medical practitioners are still having a hard time finding the right system to balance administrative tasks and patient care. Healthcare providers are struggling to keep up with the ever-increasing demands of their patients. That is why there is now a fast-growing demand for Virtual Patient Coordinators. Virtual Patient Coordinators are skilled individuals who work remotely to assist medical practices in managing their patients' needs. They are responsible for a wide range of tasks, including scheduling appointments, coordinating referrals, and organizing medical records. By utilizing advanced technology and secure communication platforms, virtual patient coordinators are able to efficiently handle these tasks from anywhere in the world, ensuring that patients receive the care they need in a timely manner. Let’s find out the ways they are changing the game for busy medical practices.
Author Interviews, Cost of Health Care, Pharmacology / 09.12.2023

MedicalResearch.com Interview with: [caption id="attachment_61125" align="alignleft" width="125"]Joseph T. DiPiro, Pharm.DAssociate Vice President, Faculty Affairs Virginia Commonwealth University Dr. DiPiro[/caption] Joseph T. DiPiro, Pharm.D Associate Vice President, Faculty Affairs Virginia Commonwealth University Dr. DiPiro is an editor for Pharmacotherapy: A Pathophysiologic Approach MedicalResearch.com: What is the background for this study? Response: The ASHP/ASHP Foundation Pharmacy Forecast Report is constructed from a survey of health-system pharmacy leaders who were asked to rate the likelihood of events, scenarios, and trends occurring in the next five years. The purpose is for health-system pharmacists and pharmacy leaders to inform their strategic planning efforts. The Pharmacy Forecast is not intended to predict future events. Rather, the report is intended to be a provocative stimulant for the thinking, discussion, and planning that must take place in every health system. Leaders must be informed of potential developments to help position their organizations to care for patients, enhance population health, and improve medication outcomes.
Author Interviews, Cancer Research, Cost of Health Care, JAMA, Pharmacology / 17.11.2023

MedicalResearch.com Interview with: Lisa-Marie Smale, PharmD PhD Candidate Clinical Pharmacy Radboud University Medical Center Department of Pharmacy Nijmegen, the Netherlands Lisa-Marie Smale, PharmDPhD Candidate Clinical PharmacyRadboud University Medical CenterDepartment of PharmacyNijmegen, the Netherlands   MedicalResearch.com: What is the background for this study? Response: Cancer drugs are not always fully used by patients, while these drugs are mostly expensive and environmentally damaging, both in production and (waste) disposal. Therefore we investigated whether unused drugs of patients can be collected, verified of quality by a pharmacy, to be redispensed to other patients instead of being disposed of. We were interested whether such an approach ultimately leads to lower environmental impacts and costs.